CDKN2A and non-Hodgkin lymphoma: In addition, in canine high-grade T-cell non-Hodgkin lymphoma (NHL) cases, deletion of the p16 gene and pRb phosphorylation reached 100% [16], suggesting that the p16 gene deletion and pRb phosphorylation are prognostically valuable parameters for canine NHL.